Clinical Trial · NCT06783088

Quantification With Lutetium-177 on Cadmium-Zinc-Telluride Camera 3D

Overview

The main of this study is to demonstrate the feasibility of carrying out quantitative acquisitions regardless of the energy peak considered (113 keV (kiloelectronVolts) or 208 keV or a combination of the 2 energy peaks). A study on phantom will optimise the reconstruction parameters. These parameters will then be applied to a population of patients who have already benefited from a recording on a 3D CZT camera (retrospective data).

Sponsor

Central Hospital, Nancy, France

Phase

N/A

Contacts

Véronique ROCH, MSc

v.roch@chru-nancy.fr

0383154276 ext +33

Laetitia IMBERT, PhD

l.imbert@chru-nancy.fr

0383157879 ext +33

ClinicalTrials.gov

NCT06783088

Drug / Compound

Isotope(s):
Target(s):
  • PSMA